Visit our Christmas Gift Finder
Adjuvant Chemotherapy of Breast Cancer: Papers Presented at the 2nd International Conference on Adjuvant Chemotherapy of Breast Cancer, Kantonsspital St. Gallen, Switzerland, March 1 - 3, 1984 - Recent Results in Cancer Research 96 (Paperback)
  • Adjuvant Chemotherapy of Breast Cancer: Papers Presented at the 2nd International Conference on Adjuvant Chemotherapy of Breast Cancer, Kantonsspital St. Gallen, Switzerland, March 1 - 3, 1984 - Recent Results in Cancer Research 96 (Paperback)
zoom

Adjuvant Chemotherapy of Breast Cancer: Papers Presented at the 2nd International Conference on Adjuvant Chemotherapy of Breast Cancer, Kantonsspital St. Gallen, Switzerland, March 1 - 3, 1984 - Recent Results in Cancer Research 96 (Paperback)

(editor)
£114.00
Paperback 246 Pages / Published: 15/12/2011
  • We can order this

Usually dispatched within 3 weeks

  • This item has been added to your basket
H.-J. Senn Adjuvant Chemotherapy (ACT) of breast cancer has now emerged as one of the controversial su):>jects in clinical and also experimental oncology. Driven by growing frustration about stagnating cure rates in breast cancer [1,4] and stimulated by elegant demonstration of highly curative effects of adjuvant systemic therapy in animal models [6, 11] and in several childhood neoplasias [15], researchers introduced ACT to the primary treatment of breast cancer with great hope some 15 years ago. After a first wave of isolated "historic" trials with generally limited but in one case remarkable success [5, 9], a second generation of ACT studies was initiated by NSABP investigators and oncology centers in Europe [2, 6, 13]. These trials were well conducted statistically and diagnostically, and all in the early 1970s included a surgical control arm. Early and intermediate beneficial effects on relapse-free survival (RFS) after 2-3 years median observation time then prompted a whole series of ACT studies in breast cancer. These "third-gener- ation" studies usually regarded some positive influence of ACT as a given fact, dropping surgical control regimens and comparing different ACT regimens, hopefully in a prospective, randomized way 1984 Fig. 1. The mushrooming of adjuvant studies in breast cancer XII Introduction [reviews in 3, 14]. The "mushrooming" of ACT studies in breast cancer during the last 10 and especially 5 years is demonstrated in Fig. 1, and it gets really cumbersome even for the insider to keep on top of the multitude of sometimes conflicting data.

Publisher: Springer-Verlag Berlin and Heidelberg GmbH & Co. KG
ISBN: 9783642823596
Number of pages: 246
Weight: 461 g
Dimensions: 244 x 170 x 14 mm
Edition: Softcover reprint of the original 1st ed. 198

You may also be interested in...

Textbook of Clinical Embryology
Added to basket
Infertility
Added to basket
£14.99
Paperback
Diseases of the Breast
Added to basket
£234.00
Hardback
MRCOG Part One
Added to basket
£96.99
Paperback
Overcoming Pms The Natural Way
Added to basket
Medical Disorders in Pregnancy
Added to basket
Obstetrics and Gynaecology
Added to basket
CTG Made Easy
Added to basket
£25.99
Paperback
Handbook of Obstetric Medicine
Added to basket
Managing PCOS For Dummies
Added to basket
The Roar Behind the Silence
Added to basket

Please sign in to write a review

Your review has been submitted successfully.